MEDIPOST Co.,Ltd.

Company Introduction

"Contains the mystery found from umbilical cord blood.
Established by doctors from university general hospitals in Korea in 2000, listed on KOSDAQ in 2005!
Medipost is a company that ranks first in the storage of umbilical cord blood in Korea. It is an umbilical cord blood stem cell research company that has developed and launched stem cell medicine for the treatment of knee cartilage for the first time in the world.

In the process of culturing stem cells from umbilical cord blood in 2009, Medipost’s research team discovered limitless life energy from the umbilical cord, which can be used to change skin.
The first life energy was obtained after numerous research and efforts.
Medipost attempted to contain the life energy in the purest and stable form.
Finally, CELLPIUM and NGF37, a cosmetic made of a Human Cord Blood Cell Conditioned Media, was born.
CELLPIUM and NGF37 will provide new energy to modern women’s sensitive skin caused by stress, time, and environmental change.

In addition, CELLPIUM and NGF37 use high premium ingredients, but they will be sold at a reasonable price to realize the skin care that every woman dreams of. "
GENERALMEMBER
  • Response Level
      less than 30%
  • Supplier Level
      More than 10 billion (KRW)
  • Transaction Level
      less than 5